An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
Authors
Keywords
-
Journal
Biomed Research International
Volume 2020, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2020-07-19
DOI
10.1155/2020/4020249
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis
- (2020) Jiyu Zhou et al. Nature Communications
- Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis
- (2020) Naoki Yoshioka et al. Scientific Reports
- CD36 plays a negative role in the regulation of lipophagy in hepatocytes through an AMPK-dependent pathway
- (2019) Yun Li et al. JOURNAL OF LIPID RESEARCH
- Farnesoid X receptor activation induces the degradation of hepatotoxic 1‐deoxysphingolipids in non‐alcoholic fatty liver disease
- (2019) Zhibo Gai et al. LIVER INTERNATIONAL
- Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk
- (2018) Vasilios G. Athyros et al. Current Vascular Pharmacology
- European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver diseas
- (2018) A. L. Sberna et al. DIABETIC MEDICINE
- Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis
- (2018) Giovanni Musso et al. GASTROENTEROLOGY
- Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
- (2018) Zobair M. Younossi et al. HEPATOLOGY
- CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis
- (2018) Lei Zhao et al. JOURNAL OF HEPATOLOGY
- Determinants of fibrosis progression and regression in NASH
- (2018) Detlef Schuppan et al. JOURNAL OF HEPATOLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic Inflammation
- (2018) Zhibo Gai et al. MOLECULAR PHARMACOLOGY
- Molecular pathways of nonalcoholic fatty liver disease development and progression
- (2018) Fernando Bessone et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation
- (2017) David Goldberg et al. GASTROENTEROLOGY
- Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice
- (2017) Vittoria Massafra et al. GASTROENTEROLOGY
- Current and future pharmacological therapies for NAFLD/NASH
- (2017) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- New trends on obesity and NAFLD in Asia
- (2017) Jian-Gao Fan et al. JOURNAL OF HEPATOLOGY
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- Statins and non-alcoholic steatohepatitis
- (2017) Vasilios G. Athyros et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
- (2017) Vasilios G. Athyros et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Under-prescription of statins in patients with non-alcoholic fatty liver disease
- (2017) M. Del Ben et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis
- (2017) Xiaoyan Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A global perspective on FOXO1 in lipid metabolism and lipid-related diseases
- (2017) Yue Li et al. PROGRESS IN LIPID RESEARCH
- Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2017) Ali Saeed et al. Nutrients
- Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies
- (2017) Christophe Kosinski et al. Nutrients
- Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis
- (2017) Hung-Wei Liao et al. BMJ Open
- Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites
- (2016) You Zhou et al. Clinical Gastroenterology and Hepatology
- Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice
- (2016) Camella G. Wilson et al. ENDOCRINOLOGY
- Emerging and future therapies for nonalcoholic steatohepatitis in adults
- (2016) Gesthimani Mintziori et al. EXPERT OPINION ON PHARMACOTHERAPY
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?
- (2016) Bin Gao et al. GASTROENTEROLOGY
- Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) A. Lonardo et al. HEPATOLOGY
- Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES
- (2016) Tracey G. Simon et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study
- (2016) Gyuri Kim et al. INTERNATIONAL JOURNAL OF CANCER
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Thiazolidinediones for nonalcoholic steatohepatitis
- (2016) Lingling He et al. MEDICINE
- Non-alcoholic fatty liver disease and risk of cardiovascular disease
- (2016) Amedeo Lonardo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Adipokines in nonalcoholic fatty liver disease
- (2016) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Immunology in the liver — from homeostasis to disease
- (2016) Felix Heymann et al. Nature Reviews Gastroenterology & Hepatology
- Ceramide Induces Human Hepcidin Gene Transcription through JAK/STAT3 Pathway
- (2016) Sizhao Lu et al. PLoS One
- Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
- (2016) Nada Pejnovic et al. WORLD JOURNAL OF GASTROENTEROLOGY
- CD36 regulates lipopolysaccharide-induced signaling pathways and mediates the internalization of Escherichia coli in cooperation with TLR4 in goat mammary gland epithelial cells
- (2016) Duoyao Cao et al. Scientific Reports
- Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells
- (2016) Nancy Magee et al. Biomed Research International
- Autophagy in the light of sphingolipid metabolism
- (2015) Eva Bang Harvald et al. APOPTOSIS
- Loss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation in female mice
- (2015) Gregory G. Martin et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse LiverSignificance
- (2015) Annie Demers et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Acetyl-CoA carboxylase 2 suppression rescues human proximal tubular cells from palmitic acid induced lipotoxicity via autophagy
- (2015) Wei Xin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells
- (2015) Lee-Won Chong et al. BMC GASTROENTEROLOGY
- Nonalcoholic fatty liver disease
- (2015) Timothy Hardy et al. CURRENT OPINION IN GASTROENTEROLOGY
- Ceramide-Initiated Protein Phosphatase 2A Activation Contributes to Arterial Dysfunction In Vivo
- (2015) Leena P. Bharath et al. DIABETES
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease
- (2015) Mary E. Rinella JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
- (2015) D. Lee Gorden et al. JOURNAL OF LIPID RESEARCH
- Dietary Milk-Fat-Globule Membrane Affects Resistance to Diarrheagenic Escherichia coli in Healthy Adults in a Randomized, Placebo-Controlled, Double-Blind Study
- (2015) Sandra J Ten Bruggencate et al. JOURNAL OF NUTRITION
- Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis
- (2015) Ahmed M. Kabel et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH
- (2015) Varenka J. Barbero-Becerra et al. TOXICOLOGY IN VITRO
- Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome
- (2015) Konstantinos Kargiotis WORLD JOURNAL OF GASTROENTEROLOGY
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
- (2015) Hannele Yki-Järvinen Nutrients
- Obesity-Induced CerS6-Dependent C16:0 Ceramide Production Promotes Weight Gain and Glucose Intolerance
- (2014) Sarah M. Turpin et al. Cell Metabolism
- CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance
- (2014) Suryaprakash Raichur et al. Cell Metabolism
- Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity
- (2014) Yajing Chu et al. CELL RESEARCH
- Effect of Rosuvastatin on Non-alcoholic Steatohepatitis in Patients with Metabolic Syndrome and Hypercholesterolaemia: A Preliminary Report
- (2014) Konstantinos Kargiotis et al. Current Vascular Pharmacology
- The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice
- (2014) Michal Pawlak et al. HEPATOLOGY
- ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis
- (2014) Raquel Fucho et al. JOURNAL OF HEPATOLOGY
- Lipid accumulation is ahead of epithelial-to-mesenchymal transition and therapeutic intervention by acetyl-CoA carboxylase 2 silence in diabetic nephropathy
- (2014) Ying Xu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet
- (2014) Ludovico Abenavoli WORLD JOURNAL OF GASTROENTEROLOGY
- Induction of ER stress-mediated apoptosis by ceramide via disruption of ER Ca2+ homeostasis in human adenoid cystic carcinoma cells
- (2014) Zhe Liu et al. Cell and Bioscience
- Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons
- (2014) Nadine Beckmann et al. Frontiers in Physiology
- The Human Liver Fatty Acid Binding Protein T94A Variant Alters the Structure, Stability, and Interaction with Fibrates
- (2013) Gregory G. Martin et al. BIOCHEMISTRY
- The adipokine/ceramide axis: Key aspects of insulin sensitization
- (2013) Jonathan Y. Xia et al. BIOCHIMIE
- Are statins ‘IDEAL’ for non-alcoholic fatty liver disease?
- (2013) Vasilios G. Athyros et al. CURRENT MEDICAL RESEARCH AND OPINION
- Peroxisome proliferator-activated receptor δ
- (2013) Lazar A. Bojic et al. CURRENT OPINION IN LIPIDOLOGY
- Sugar, Uric Acid, and the Etiology of Diabetes and Obesity
- (2013) R. J. Johnson et al. DIABETES
- Dual Peroxisome Proliferator-Activated Receptor / Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
- (2013) B. Cariou et al. DIABETES CARE
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasingde novosynthesis of long-chain ceramides
- (2013) Resat Cinar et al. HEPATOLOGY
- Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
- (2013) Matti J. Tikkanen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy
- (2013) Xavier Palomer et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy
- (2013) Michal Herman-Edelstein et al. JOURNAL OF LIPID RESEARCH
- Inhibition of ceramidede novosynthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease
- (2013) Krzysztof Kurek et al. LIVER INTERNATIONAL
- Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability
- (2013) Utpal B Pajvani et al. NATURE MEDICINE
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
- (2013) Alexander Wree et al. Nature Reviews Gastroenterology & Hepatology
- Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats
- (2013) Lang Shen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease
- (2012) Rebecca C. Schugar et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Pathogenesis and Treatment Options
- (2012) Konstantinos Tziomalos et al. Current Vascular Pharmacology
- Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
- (2012) Siddharth Singh et al. GASTROENTEROLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
- (2012) Shira Zelber-Sagi et al. JOURNAL OF HEPATOLOGY
- Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats
- (2012) Yoshihisa Okada et al. LIVER INTERNATIONAL
- Exercise in the Metabolic Syndrome
- (2012) Saeid Golbidi et al. Oxidative Medicine and Cellular Longevity
- Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis
- (2011) E. Boettcher et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study
- (2011) Maria Maersk et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
- (2011) Timothy R. Peterson et al. CELL
- Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT): A Prospective-Randomized Study in Middle Aged Men and Women
- (2011) Vassilios G. Athyros et al. Current Vascular Pharmacology
- Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C
- (2011) M. E. Miquilena-Colina et al. GUT
- Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
- (2011) Silvia Sookoian et al. HEPATOLOGY
- Hepatic angiogenesis and fibrosis are common features in morbidly obese patients
- (2011) Monika Ciupińska-Kajor et al. Hepatology International
- Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats
- (2011) Tomokatsu Miyaki et al. HEPATOLOGY RESEARCH
- Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels
- (2011) Kittichai Promrat et al. HEPATOLOGY RESEARCH
- Membrane-rich milk fat diet provides protection against gastrointestinal leakiness in mice treated with lipopolysaccharide
- (2011) D.R. Snow et al. JOURNAL OF DAIRY SCIENCE
- Yes! Statins can be given to liver patients
- (2011) Ted Bader JOURNAL OF HEPATOLOGY
- Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2011) Helen M. Parker et al. JOURNAL OF HEPATOLOGY
- Comparison of Dietary Control and Atorvastatin on High Fat Diet Induced Hepatic Steatosis and Hyperlipidemia in Rats
- (2011) Guiyuan Ji et al. Lipids in Health and Disease
- Lipid body function in eicosanoid synthesis: An update
- (2011) Patricia T. Bozza et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Hepatic FXR: key regulator of whole-body energy metabolism
- (2011) João Soeiro Teodoro et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The effect of milk polar lipids separated from butter serum on the lipid levels in the liver and the plasma of obese-model mouse (KK-Ay)
- (2011) Shiomi Watanabe et al. Journal of Functional Foods
- Increased Arterial Stiffness and Impaired Endothelial Function in Nonalcoholic Fatty Liver Disease: A Pilot Study
- (2010) Charalambos Vlachopoulos et al. AMERICAN JOURNAL OF HYPERTENSION
- Acidic Sphingomyelinase Controls Hepatic Stellate Cell Activation and in Vivo Liver Fibrogenesis
- (2010) Anna Moles et al. AMERICAN JOURNAL OF PATHOLOGY
- Genetic control ofde novolipogenesis: role in diet-induced obesity
- (2010) Maggie S. Strable et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Inhibition of De Novo Ceramide Synthesis Reverses Diet-Induced Insulin Resistance and Enhances Whole-Body Oxygen Consumption
- (2010) J. R. Ussher et al. DIABETES
- Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men
- (2010) H. Sobrecases et al. DIABETES & METABOLISM
- Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia
- (2010) P. Matafome et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Chemokines as Immune Mediators of Liver Diseases Related to the Metabolic Syndrome
- (2010) Marie-Luise Berres et al. DIGESTIVE DISEASES
- Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
- (2010) Judith Ertle et al. INTERNATIONAL JOURNAL OF CANCER
- A position statement on NAFLD/NASH based on the EASL 2009 special conference
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
- (2010) Vasilios G Athyros et al. LANCET
- Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis
- (2010) Shijie Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment
- (2010) Laia Vilà et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Omega-3 Fatty Acids and Inflammatory Processes
- (2010) Philip C. Calder Nutrients
- Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome
- (2009) Guang Yang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells
- (2009) Hella Wobser et al. CELL RESEARCH
- The plasma lipidomic signature of nonalcoholic steatohepatitis
- (2009) Puneet Puri et al. HEPATOLOGY
- Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome
- (2009) Ali Abid et al. JOURNAL OF HEPATOLOGY
- Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1
- (2009) Hiroyuki Seki et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
- (2009) R. L. Silverstein et al. Science Signaling
- Cellular fatty acid uptake: a pathway under construction
- (2009) Xiong Su et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
- (2009) Naim Alkhouri et al. Expert Review of Gastroenterology & Hepatology
- Gene expression in human NAFLD
- (2008) Dario Greco et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice
- (2008) Gergana M. Deevska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
- (2008) Tae-Sik Park et al. JOURNAL OF LIPID RESEARCH
- Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
- (2008) Hideyuki Hyogo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Sphingomyelin Functions as a Novel Receptor for Helicobacter pylori VacA
- (2008) Vijay R. Gupta et al. PLoS Pathogens
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started